Stockscreener 앱 받기
42.77
2.52%
1.05
전일 마감가:
$41.72
열려 있는:
$41.63
하루 거래량:
202.93K
Relative Volume:
0.71
시가총액:
$1.91B
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+6.16%
1개월 성능:
+16.92%
6개월 성능:
+151.74%
1년 성능:
+0.00%
1일 변동 폭
$41.32
$43.20
1주일 범위
$39.91
$43.20
52주 변동 폭
$7.255
$45.00
Sionna Therapeutics Inc Stock (SION) Company Profile
명칭
Sionna Therapeutics Inc
전화
617-819-2020
주소
21 HICKORY DRIVE, SUITE 500, WALTHAM
SION을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SION
Sionna Therapeutics Inc
|
42.77 | 1.86B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Sionna Therapeutics Inc Stock (SION) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-01 | 다운그레이드 | RBC Capital Mkts | Sector Perform → Underperform |
| 2025-11-19 | 개시 | BTIG Research | Buy |
| 2025-09-03 | 개시 | RBC Capital Mkts | Sector Perform |
| 2025-09-03 | 개시 | Raymond James | Strong Buy |
| 2025-03-04 | 개시 | Guggenheim | Buy |
| 2025-03-04 | 개시 | Stifel | Buy |
| 2025-03-04 | 개시 | TD Cowen | Buy |
모두보기
Sionna Therapeutics Inc 주식(SION)의 최신 뉴스
Sionna Therapeutics, Inc. Rings the Closing Bell - Nasdaq
Braidwell LP Invests $18.77 Million in Sionna Therapeutics, Inc. $SION - MarketBeat
Sionna Therapeutics (NASDAQ:SION) Upgraded at Wall Street Zen - MarketBeat
Sionna Therapeutics, Inc. (NASDAQ:SION) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Sionna Therapeutics, Inc. (NASDAQ:SION) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Sionna Therapeutics chief legal officer sells $415,330 in stock By Investing.com - Investing.com India
Sionna Therapeutics chief legal officer sells $415,330 in stock - Investing.com
Sionna Therapeutics Insider Sold Shares Worth $415,330, According to a Recent SEC Filing - marketscreener.com
Bosun Asset Management LLC Invests $295,000 in Sionna Therapeutics, Inc. $SION - Defense World
Officer Fitzpatrick Files To Sell 10,250 Of Sionna Therapeutics Inc [SION] - TradingView
Sionna Therapeutics, Inc. $SION Shares Acquired by Prudential Financial Inc. - MarketBeat
Sionna Therapeutics (NASDAQ:SION) Shares Up 11.4%What's Next? - MarketBeat
Sionna Therapeutics Valuation Topping $2 Billion Is 'Too Optimistic', RBC Says - marketscreener.com
Transcript : Sionna Therapeutics, Inc. Presents at Citi Annual Global Healthcare Conference 2025, Dec-04-2025 09 - marketscreener.com
Why Sionna Therapeutics Inc. stock remains resilient2025 Short Interest & Long-Term Growth Portfolio Plans - Newser
Will Sionna Therapeutics Inc. stock gain from government policies - Newser
Sionna Therapeutics, Inc. $SION Shares Purchased by JPMorgan Chase & Co. - MarketBeat
Sionna Therapeutics (NASDAQ:SION) Shares Gap DownHere's What Happened - MarketBeat
Views of Wall Street’s Leading Experts on Sionna Therapeutics Inc - Setenews
Royal Bank Of Canada Reiterates "Underperform" Rating for Sionna Therapeutics (NASDAQ:SION) - MarketBeat
Is Sionna Therapeutics Inc. stock affected by interest rate hikesGold Moves & Precise Entry and Exit Recommendations - Newser
Sionna Therapeutics Shares Lower After RBC Downgrade - marketscreener.com
Sionna Therapeutics stock tumbles after RBC downgrade By Investing.com - Investing.com Canada
SION Downgraded by RBC Capital: Today's Analyst Rating | SION St - GuruFocus
RBC Capital downgrades Sionna Therapeutics stock on valuation concerns By Investing.com - Investing.com Canada
RBC Downgrades Sionna Therapeutics to Underperform From Sector Perform, Keeps $24 Price Target, Speculative Risk - marketscreener.com
Sionna Therapeutics (NASDAQ:SION) Stock Price Down 3.9%Should You Sell? - MarketBeat
What drives Sionna Therapeutics Inc stock priceEarnings Forecast Updates & Rapid Capital Trading - earlytimes.in
Sionna Therapeutics (SION): Examining Valuation Following Recent Share Price Surge - Sahm
Sionna Therapeutics Insider Sold Shares Worth $4,814,205, According to a Recent SEC Filing - marketscreener.com
OrbiMed Advisors sells Sionna Therapeutics (SION) stock worth $4.8m By Investing.com - Investing.com Nigeria
Insider Selling: Sionna Therapeutics (NASDAQ:SION) Director Sells 1,600 Shares of Stock - MarketBeat
OrbiMed Advisors sells Sionna Therapeutics (SION) stock worth $4.8m - Investing.com India
Shareholder OrbiMed Advisors LLC Sells 108,073 ($4.8M) Of Sionna Therapeutics Inc [SION] - TradingView
Insider Selling: Sionna Therapeutics (NASDAQ:SION) Director Sells 25,183 Shares of Stock - MarketBeat
Major Stock Sale Alert: Sionna Therapeutics Shares on the Move! - TipRanks
Shareholder Orbimed Private Investments Viii Lp Files To Sell 1,047,770 Of Sionna Therapeutics Inc [SION] - TradingView
Owner RA Capital Management LP Sells 30,316 ($1.2M) Of Sionna Therapeutics Inc [SION] - TradingView
RA Capital funds report SION insider stock sales in Form 4 filing - Stock Titan
SION Crosses Above Average Analyst Target - Nasdaq
Sionna Therapeutics to Participate in Upcoming December Investor Conferences - The Manila Times
Sionna Therapeutics (NASDAQ:SION) Hits New 1-Year HighHere's What Happened - MarketBeat
Owner Blackwell Partners LLC-Series A Files To Sell 7,609 Of Sionna Therapeutics Inc [SION] - TradingView
Is Sionna Therapeutics Inc. stock a smart buy before Fed meetingGap Down & High Yield Equity Trading Tips - newser.com
Will Sionna Therapeutics Inc. stock reach Wall Street targetsMarket Risk Report & Reliable Intraday Trade Alerts - newser.com
Sionna Therapeutics (NASDAQ:SION) Upgraded at BTIG Research - Defense World
Sionna Therapeutics (NASDAQ:SION) Director Ra Capital Management, L.P. Sells 47,442 Shares - MarketBeat
Ra Capital sold Sionna Therapeutics (SION) shares worth $5.5m By Investing.com - Investing.com Nigeria
Sionna Therapeutics Inc (SION) 재무 분석
Sionna Therapeutics Inc (SION)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
Sionna Therapeutics Inc 주식 (SION) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Fitzpatrick Jennifer | Chief Legal Officer |
Dec 05 '25 |
Sale |
40.52 |
10,250 |
415,330 |
0 |
1.08%
0.91%
자본화:
|
볼륨(24시간):